These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15871716)

  • 21. The effect of octreotide on parathyroid carcinoma.
    Denney AM; Watts NB
    J Clin Endocrinol Metab; 2004 Feb; 89(2):1016. PubMed ID: 14764832
    [No Abstract]   [Full Text] [Related]  

  • 22. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.
    Vezzosi D; Bennet A; Courbon F; Caron P
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):904-11. PubMed ID: 18031316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it time to widen the use of somatostatin analogs in neuroendocrine tumors?
    Oberg KE
    J Clin Oncol; 2009 Oct; 27(28):4635-6. PubMed ID: 19704053
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-surgical management of a lymphatic fistula, after laparoscopic colorectal surgery, with total parenteral nutrition, octreotide, and somatostatin.
    Giovannini I; Giuliante F; Chiarla C; Ardito F; Vellone M; Nuzzo G
    Nutrition; 2005 Oct; 21(10):1065-7. PubMed ID: 16157245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G; Bettini R; Missiaglia E; Mantovani W; Dalai I; Capelli P; Ferdeghini M; Pederzoli P; Scarpa A; Falconi M
    Endocr Relat Cancer; 2006 Dec; 13(4):1213-21. PubMed ID: 17158766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

  • 27. [Update on the anesthetic management of patients with malignant carcinoid syndrome].
    Rodríguez-Cosmen C; Trillo Urrutia L; Pacreu Terradas S; Comps Vicente O; Escolano Villén F
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):291-4. PubMed ID: 15968907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of surgery in the management of older women with breast cancer.
    Wyld L; Reed M
    Eur J Cancer; 2007 Oct; 43(15):2253-63. PubMed ID: 17904836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings of the 1st Annual Octreotide LAR Investigators' Workshop in Oncology. Role of Octreotide in Cancer and Therapy-Related Complications. April 2002.
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 8):7-24. PubMed ID: 12387268
    [No Abstract]   [Full Text] [Related]  

  • 30. First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.
    Colao A; Pivonello R; Rosato F; Tita P; De Menis E; Barreca A; Ferrara R; Mainini F; Arosio M; Lombardi G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):342-51. PubMed ID: 16487447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response of ACTH to octreotide in a probable corticotropic adenoma associated with Addison's disease.
    Suárez-Llanos JP; Fernández-Fernández E; Checa MR; Jara-Albarrán A
    Neuro Endocrinol Lett; 2007 Oct; 28(5):549-53. PubMed ID: 17984930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study.
    Barbare JC; Bouché O; Bonnetain F; Dahan L; Lombard-Bohas C; Faroux R; Raoul JL; Cattan S; Lemoine A; Blanc JF; Bronowicki JP; Zarski JP; Cazorla S; Gargot D; Thevenot T; Diaz E; Bastie A; Aparicio T; Bedenne L
    Eur J Cancer; 2009 Jul; 45(10):1788-97. PubMed ID: 19303768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible increased risk of pulmonary edema in patients with hepatorenal syndrome on adding octreotide to albumin / noradrenaline therapies.
    Abutaleb N
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):261. PubMed ID: 17496406
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ; Dixon JM
    Breast J; 2007; 13(3):243-50. PubMed ID: 17461898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Well-differentiated endocrine carcinoma of the renal pelvis: report of a case with sustained objective response to octreotide.
    Walter T; Mege-Lechevallier F; Scoazec JY; Martin X; Chayvialle JA; Lombard-Bohas C
    Pathol Res Pract; 2009; 205(3):183-7. PubMed ID: 19041194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single-centre experience with octreotide in the treatment of different hypersecretory syndromes in patients with functional gastroenteropancreatic neuroendocrine tumors.
    Berković MC; Altabas V; Herman D; Hrabar D; Goldoni V; Vizner B; Zjacić-Rotkvić V
    Coll Antropol; 2007 Jun; 31(2):531-4. PubMed ID: 17847934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma.
    Glas M; Hennemann B; Hirschmann B; Marienhagen J; Schmidt-Wolf I; Herrlinger U; Bogdahn U; Hau P
    Acta Oncol; 2008; 47(3):479-80. PubMed ID: 17934891
    [No Abstract]   [Full Text] [Related]  

  • 38. Octreotide: no benefit in advanced liver cancer.
    Tilstone C
    Lancet Oncol; 2007 Feb; 8(2):103. PubMed ID: 17288044
    [No Abstract]   [Full Text] [Related]  

  • 39. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant endocrine therapy for breast cancer: more questions than answers.
    Ellis MJ
    J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.